Elevance Health (ELV) Stock News
$ELV · NYSE · HEALTHCARE · 2 stories in 30 daysBORSA has published 2 stories on Elevance Health (ELV) in the past 30 days, 1 of them high impact. BORSA’s news read on ELV is bullish at 77/100, based on 2 company events over the past 7 days. ELV last closed at $440.18 on Oct 20, up 3.51% over five sessions and up 7.54% over the past month. Elevance Health last reported quarterly results on Jul 15, 2026, for the quarter ended Jun 30, 2026.
The wire on $ELV
newest first · updated · direct subject stories onlyElevance Health beat Q3 estimates with adjusted EPS of $6.99, though $1.85 was nonoperating. Revenue topped forecasts. The company raised full-year guidance and sees at least 12% earnings growth in 2027. Medical cost ratio improved. Stock closed down 1.37%.
neutral 50 · impact 60Elevance Health lifted its 2026 EPS guidance to at least $22 ($29 adjusted) after a strong third quarter. Adjusted EPS of $6.99 beat the $4.71 consensus. Revenue rose to $51.43 billion, topping forecasts. Membership fell by 487,000.